News & Press Releases

Member Marguerite McConihe was quoted by 9fin in an article about the opportunities and risks associated with the use of AI technologies in leveraged finance. The article notes that while LevFin bankers have largely benefitted from AI, questions are emerging around credit risk, cyber security vulnerabilities, and treating AI-generated assets or IP as debt collateral.

At Bisnow’s DICE: South event in Dallas this month, Member Jeffrey Moerdler participated in a discussion with other industry leaders about how investors may be overlooking data center acquisitions. Bisnow quoted Jeffrey in a recent article about the takeaways from the event.

Mintz advised the lead placement agent in connection with an up to $50 million private placement by Equillium, Inc. The PIPE was comprised of (i) an initial upfront closing of approximately $30 million in gross proceeds in exchange for approximately 52.6 million shares of common stock (or, for certain investors, pre-funded warrants in lieu of common stock), and (ii) the potential for up to an additional $20 million in gross proceeds in exchange for up to approximately 35.1 million shares of common stock (or, for certain investors, pre-funded warrants in lieu of common stock), subject to achieving specified milestones related to clinical study initiation and share price.

In a recent Agenda article, Member Jennifer Rubin shared insights about security and emergency planning for companies facing high-risk incidents. Following the tragic shooting at a Manhattan office building in late July, the piece explores how companies can communicate effectively with investors, maintain strong oversight, and protect employees amid growing concerns about workplace safety.

Mintz announces that eleven of its attorneys have been named to the 2025 IAM Strategy 300: The World's Leading IP Strategists list, which recognizes individuals for their trailblazing work in developing and implementing strategies that maximize the value of intellectual property portfolios.

Member Theresa Carnegie connected with Endpoints News about the pharmaceutical industry's continued legal challenges to the Inflation Reduction Act, even as the federal government has prevailed in about a dozen cases so far. AstraZeneca, one of the companies still pushing back, recently requested more time to petition the Supreme Court following a loss in the Third Circuit.